Ajay Duggal

775 total citations
14 papers, 567 citations indexed

About

Ajay Duggal is a scholar working on Nephrology, Surgery and Nutrition and Dietetics. According to data from OpenAlex, Ajay Duggal has authored 14 papers receiving a total of 567 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Nephrology, 4 papers in Surgery and 3 papers in Nutrition and Dietetics. Recurrent topics in Ajay Duggal's work include Parathyroid Disorders and Treatments (4 papers), Magnesium in Health and Disease (3 papers) and Platelet Disorders and Treatments (2 papers). Ajay Duggal is often cited by papers focused on Parathyroid Disorders and Treatments (4 papers), Magnesium in Health and Disease (3 papers) and Platelet Disorders and Treatments (2 papers). Ajay Duggal collaborates with scholars based in United Kingdom, United States and Japan. Ajay Duggal's co-authors include Roy Reeve, P A Kalra, S. A. Roberts, Stanley Fan, Scott Chasan-Taber, Silvia Carreira Ribeiro, Hartmut H. Malluche, Aníbal Ferreira, José Guilherme Ferreira Marques Galvão and Yanbin Dong and has published in prestigious journals such as Blood, Gastroenterology and Hepatology.

In The Last Decade

Ajay Duggal

14 papers receiving 544 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ajay Duggal United Kingdom 10 305 185 140 89 82 14 567
A. Lehnhardt Germany 13 184 0.6× 50 0.3× 147 1.1× 139 1.6× 62 0.8× 23 559
Shinobu Waga Japan 14 246 0.8× 35 0.2× 131 0.9× 79 0.9× 47 0.6× 58 560
C. Stallone Italy 10 225 0.7× 23 0.1× 113 0.8× 57 0.6× 65 0.8× 26 607
María Dolores Checa Spain 10 203 0.7× 27 0.1× 76 0.5× 168 1.9× 81 1.0× 14 553
O Otsubo Japan 14 174 0.6× 30 0.2× 40 0.3× 108 1.2× 34 0.4× 38 512
Wolfgang Grotz Germany 11 292 1.0× 24 0.1× 139 1.0× 114 1.3× 55 0.7× 18 811
Karine Brochard France 12 124 0.4× 31 0.2× 96 0.7× 248 2.8× 56 0.7× 23 794
Alberto Santoboni Italy 8 237 0.8× 34 0.2× 103 0.7× 82 0.9× 27 0.3× 26 482
Alper Azak Türkiye 12 314 1.0× 19 0.1× 50 0.4× 161 1.8× 85 1.0× 32 465
Mariano Forrester Argentina 14 228 0.7× 17 0.1× 145 1.0× 64 0.7× 69 0.8× 42 490

Countries citing papers authored by Ajay Duggal

Since Specialization
Citations

This map shows the geographic impact of Ajay Duggal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ajay Duggal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ajay Duggal more than expected).

Fields of papers citing papers by Ajay Duggal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ajay Duggal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ajay Duggal. The network helps show where Ajay Duggal may publish in the future.

Co-authorship network of co-authors of Ajay Duggal

This figure shows the co-authorship network connecting the top 25 collaborators of Ajay Duggal. A scholar is included among the top collaborators of Ajay Duggal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ajay Duggal. Ajay Duggal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Vincenzi, Bruno, Ajay Duggal, Pamela Guglielmini, et al.. (2020). Neurokinin-1 antagonist orvepitant for EGFRI-induced pruritus in patients with cancer: a randomised, placebo-controlled phase II trial. BMJ Open. 10(2). e030114–e030114. 11 indexed citations
2.
Peck‐Radosavljevic, Markus, Krzysztof Simon, A. Iacobellis, et al.. (2019). Lusutrombopag for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Invasive Procedures (L‐PLUS 2). Hepatology. 70(4). 1336–1348. 97 indexed citations
3.
Ousler, George W, Gail Torkildsen, Claire A. Walshe, et al.. (2019). <p>A phase 2 randomized, double-masked, placebo-controlled study of novel nonsystemic kinase inhibitor TOP1630 for the treatment of dry eye disease</p>. Clinical ophthalmology. Volume 13. 261–275. 14 indexed citations
4.
5.
Rowley, Ann, Ajay Duggal, Yemisi Solanke, et al.. (2018). P359 A novel phase 1 trial design to evaluate safety, tolerability, pharmacokinetics, and pharmacodynamics of TOP1288, a narrow spectrum kinase inhibitor, delivered topically to the colon via oral administration. Journal of Crohn s and Colitis. 12(supplement_1). S285–S286. 1 indexed citations
6.
7.
Duggal, Ajay, Adele Rowley, Meika Foster, et al.. (2017). P684 A first clinical trial of a novel narrow spectrum kinase inhibitor TOP1288 in patients with ulcerative colitis. Journal of Crohn s and Colitis. 11(suppl_1). S429–S430. 1 indexed citations
8.
Ferreira, Aníbal, et al.. (2008). Effects of Sevelamer Hydrochloride and Calcium Carbonate on Renal Osteodystrophy in Hemodialysis Patients. Journal of the American Society of Nephrology. 19(2). 405–412. 140 indexed citations
9.
Evenepoel, Pieter, Rafael Selgas, Lukas Foggensteiner, et al.. (2008). Efficacy and safety of sevelamer hydrochloride and calcium acetate in patients on peritoneal dialysis. Nephrology Dialysis Transplantation. 24(1). 278–285. 59 indexed citations
10.
Ketteler, Markus, Marianne Rix, Stanley Fan, et al.. (2008). Efficacy and Tolerability of Sevelamer Carbonate in Hyperphosphatemic Patients Who Have Chronic Kidney Disease and Are Not on Dialysis. Clinical Journal of the American Society of Nephrology. 3(4). 1125–1130. 66 indexed citations
11.
Duggal, Ajay, et al.. (2006). Novel Dosage Forms and Regimens for Sevelamer-Based Phosphate Binders. Journal of Renal Nutrition. 16(3). 248–252. 16 indexed citations
12.
Baker, Emma H., et al.. (2002). Amiloride, a Specific Drug for Hypertension in Black People With T594M Variant?. Hypertension. 40(1). 13–17. 60 indexed citations
13.
Duggal, Ajay, et al.. (2001). Clinicopathological correlation in biopsy‐proven atherosclerotic nephropathy: implications for renal functional outcome in atherosclerotic renovascular disease. Nephrology Dialysis Transplantation. 16(4). 765–770. 81 indexed citations
14.
Sharpstone, D, Ajay Duggal, & Brian Gazzard. (1996). Inflammatory bowel disease in individuals seropositive for the human immunodeficiency virus. European Journal of Gastroenterology & Hepatology. 8(6). 575–578. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Lehnhardt Breakdown of academic impact, for papers by Shinobu Waga Breakdown of academic impact, for papers by C. Stallone Breakdown of academic impact, for papers by María Dolores Checa Breakdown of academic impact, for papers by O Otsubo Breakdown of academic impact, for papers by Wolfgang Grotz Breakdown of academic impact, for papers by Karine Brochard Breakdown of academic impact, for papers by Alberto Santoboni Breakdown of academic impact, for papers by Alper Azak Breakdown of academic impact, for papers by Mariano Forrester
Rankless by CCL
2026